HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Volker Diehl Selected Research

Hodgkin Disease (Hodgkin's Disease)

6/2021PET-guided eBEACOPP treatment of advanced-stage Hodgkin lymphoma (HD18): follow-up analysis of an international, open-label, randomised, phase 3 trial.
4/2021Intensified treatment of patients with early stage, unfavourable Hodgkin lymphoma: long-term follow-up of a randomised, international phase 3 trial of the German Hodgkin Study Group (GHSG HD14).
1/2021PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.
1/2021Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group.
11/2019Positron Emission Tomography-Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
10/2018Intensive treatment strategies in advanced-stage Hodgkin's lymphoma (HD9 and HD12): analysis of long-term survival in two randomised trials.
12/2017PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group.
12/2017Incorporation of brentuximab vedotin into first-line treatment of advanced classical Hodgkin's lymphoma: final analysis of a phase 2 randomised trial by the German Hodgkin Study Group.
12/2017Reduced-Intensity Chemotherapy in Patients With Advanced-Stage Hodgkin Lymphoma: Updated Results of the Open-Label, International, Randomised Phase 3 HD15 Trial by the German Hodgkin Study Group.
1/2017Progression-free survival of early interim PET-positive patients with advanced stage Hodgkin's lymphoma treated with BEACOPPescalated alone or in combination with rituximab (HD18): an open-label, international, randomised phase 3 study by the German Hodgkin Study Group.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Volker Diehl Research Topics

Disease

77Hodgkin Disease (Hodgkin's Disease)
06/2021 - 01/2002
28Neoplasms (Cancer)
11/2019 - 01/2002
13Lymphoma (Lymphomas)
02/2010 - 01/2002
7Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2021 - 06/2002
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
03/2014 - 03/2004
3Disease Progression
01/2013 - 03/2004
3B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2012 - 03/2002
3Infertility (Sterility)
01/2008 - 07/2005
2Fatigue
10/2016 - 05/2010
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
03/2014 - 04/2004
2Residual Neoplasm
11/2011 - 07/2005
2Pathologic Complete Response
11/2008 - 07/2004
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
06/2006 - 11/2004
2Polycythemia (Erythrocytosis)
06/2005 - 01/2005
2Fever (Fevers)
03/2004 - 11/2002
1Mucositis
01/2021
1Deglutition Disorders (Dysphagia)
01/2021
1Second Primary Neoplasms (Neoplasms, Second)
01/2020
1Hypogonadism (Hypergonadotropic Hypogonadism)
01/2013
1Frailty
09/2011
1Anemia
05/2010
1Azoospermia
01/2008
1Amenorrhea
10/2005
1Colorectal Neoplasms (Colorectal Cancer)
08/2005
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
07/2004
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
07/2004
1Refractory Anemia with Excess of Blasts (RAEM)
04/2004
1Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
04/2004
1Critical Illness (Critically Ill)
03/2004
1Leukemia
03/2004

Drug/Important Bio-Agent (IBA)

23Bleomycin (Blenoxane)FDA LinkGeneric
06/2021 - 01/2002
23Doxorubicin (Adriamycin)FDA LinkGeneric
06/2021 - 01/2002
19Cyclophosphamide (Cytoxan)FDA LinkGeneric
06/2021 - 01/2002
18Vincristine (Oncovin)FDA LinkGeneric
06/2021 - 01/2002
17Prednisone (Sone)FDA LinkGeneric
06/2021 - 01/2002
17Procarbazine (Matulane)FDA Link
06/2021 - 01/2002
16Etoposide (VP 16)FDA LinkGeneric
06/2021 - 01/2002
11Dacarbazine (DIC)FDA LinkGeneric
04/2021 - 01/2002
10Vinblastine (Vinblastine Sulfate)FDA Link
04/2021 - 01/2002
7Rituximab (Mabthera)FDA Link
01/2017 - 03/2002
6Proteins (Proteins, Gene)FDA Link
07/2005 - 01/2002
5Monoclonal AntibodiesIBA
02/2014 - 10/2002
4Dexamethasone (Maxidex)FDA LinkGeneric
12/2017 - 06/2002
4Cytarabine (Cytosar-U)FDA LinkGeneric
12/2010 - 06/2002
4Methotrexate (Mexate)FDA LinkGeneric
02/2010 - 01/2002
3CytokinesIBA
01/2013 - 09/2003
2Pharmaceutical PreparationsIBA
12/2017 - 02/2007
2Interleukin-10 (Interleukin 10)IBA
01/2013 - 11/2008
2GemcitabineFDA Link
01/2008 - 06/2004
2Biological ProductsIBA
10/2007 - 06/2005
2Hemoglobins (Hemoglobin)IBA
06/2005 - 01/2005
1Immunoconjugates (Immunoconjugate)IBA
12/2017
1Brentuximab VedotinIBA
12/2017
1Ki-1 AntigenIBA
02/2014
1Mechlorethamine (Nitrogen Mustard)FDA Link
09/2013
14-(2-oxapentadeca-4-yne)phenylpropanoic acidIBA
09/2013
1Testosterone (Sustanon)FDA Link
01/2013
1Hormones (Hormone)IBA
01/2013
1idelalisibIBA
02/2012
1Protein Isoforms (Isoforms)IBA
02/2012
1Cisplatin (Platino)FDA LinkGeneric
12/2010
1Epoetin Alfa (Epogen)FDA Link
05/2010
1HLA-DR Antigens (HLA-DR)IBA
01/2007
1Glycophorins (Glycophorin C)IBA
01/2007
1Surface Antigens (Surface Antigen)IBA
01/2007
1pegfilgrastim (Neulasta)FDA Link
04/2006
1Oral ContraceptivesIBA
10/2005
1Fluorouracil (Carac)FDA LinkGeneric
08/2005
1DNA (Deoxyribonucleic Acid)IBA
08/2005
1Leucovorin (Folinic Acid)FDA Link
08/2005
1Carcinoembryonic AntigenIBA
08/2005
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
08/2005
1Interleukin-2 (IL2)IBA
08/2005
1Irinotecan (Camptosar)FDA LinkGeneric
08/2005
1Peptides (Polypeptides)IBA
08/2005
1Chemokine CCL17IBA
07/2005
1GATA2 Transcription FactorIBA
12/2004
1Interferon-alpha (Interferon Alfa)IBA
11/2004
1Transcription Factors (Transcription Factor)IBA
07/2004
1NF-kappa B (NF-kB)IBA
07/2004
1NF-KappaB Inhibitor alphaIBA
07/2004
1Topotecan (Hycamtin)FDA LinkGeneric
04/2004
1Glutamine (L-Glutamine)FDA Link
03/2004
1DipeptidesIBA
03/2004

Therapy/Procedure

42Drug Therapy (Chemotherapy)
04/2021 - 01/2002
36Radiotherapy
01/2021 - 01/2002
29Therapeutics
10/2018 - 01/2002
7Combination Drug Therapy (Combination Chemotherapy)
12/2017 - 01/2003
6Stem Cell Transplantation
12/2010 - 06/2002
6Immunotherapy
12/2005 - 11/2002
5Aftercare (After-Treatment)
01/2021 - 01/2003
3Transplantation
08/2005 - 06/2002
1Drug Tapering
08/2015
1Complementary Therapies (Alternative Medicine)
01/2009
1Induction Chemotherapy
12/2005
1Chemoradiotherapy
11/2004
1Hematopoietic Stem Cell Transplantation
07/2004
1Highly Active Antiretroviral Therapy (HAART)
06/2004
1Bone Marrow Transplantation (Transplantation, Bone Marrow)
03/2004
1Parenteral Nutrition
03/2004